News

St. Anna CCRI wants to develop new drug against Ewing sarcoma with international partners A three-year project aims to improve the long-term survival rate of patients with Ewing sarcoma. (Vienna, 22.02.2024) Ewing sarcoma is a very aggressive, rapidly metastasizing bone cancer. In Austria, five to eight children and adolescents are affected every year. The long-term […]

Wolf vs. Sheep – Game Release on International Childhood Cancer Day 2024 (Vienna, 15.2.2023) Today, we stand united under the golden ribbon – it’s International Childhood Cancer Day. A day to reflect on the fact that children aren’t simply „little“ adults, and their cancer journey demands dedicated research for tailored treatments. Bioinformatics plays a crucial role

CML: A new combination therapy against resistant leukemia (Vienna, 6.2.2024) In a new publication in the American Journal of Hematology, scientists at St. Anna Children’s Cancer Research Institute show a treatment option for chronic myeloid leukemia with highly resistant multiple mutations that have eluded previous therapies. Chronic myeloid leukemia (CML) is a slowly progressing cancer. It

World Cancer Day 2024: Collaboration is Key (Vienna, 4.2.2024) Todays World Cancer Day reminds us of the urgent need for a collective effort in understanding Childhood Cancer and enhancing treatments for children bravely facing this formidable disease. In the realm of Childhood Cancer, international collaboration is paramount. Recognizing that individual nations working in isolation would not be

Exploring Horizons: SIOPEN Translational Research Meeting in Vienna (Vienna, 31.1.2024) Over the past three days, scientists from leading institutes such as St. Anna CCRI, Charite, Curie, Prinses Maxima Center, University of Leeds and the Vall d’Hebron University Hospital engaged in dynamic discussions on pivotal topics, spanning the realms of Liquid Biopsies, Tumor Biology, and New

Neuroblastoma: Liquid biopsies to detect relapse of childhood cancer early (Vienna, 29.1.2024) Neuroblastoma mainly affects toddlers and young children – in the EU region there are 1500 new cases per year. Neuroblastoma is a malignant tumor of the peripheral nervous system and around 50% of patients are high-risk cases. Recurrences occur frequently, and conventional therapies are

CCRI – CeMM Collaboration Agreement (Vienna, 22.01.2024) CCRI Directors Kaan Boztug and Jörg Bürger, and CeMM Directors Giulio Superti-Furga and Anita Ender have signed a partnership agreement which further strengthens scientific collaborations and training aspects.  CeMM’s research is strongly oriented towards medical needs and integrates research on fundamental biological processes with clinical expertise to gain

“Don’t let obstacles deter you.”  (Vienna, 22.12.2023) Journalist Christian Rainer in a nutshell: what he would do if he were 16 years old again, how he deals with criticism and what he would like to change in the world, he told us in the “Reaching for the stars” interview! Under the motto of our 35th anniversary

Inaugural International Workshop on Innovative Models for Neuroblastoma Research (Vienna, 15.12.2023) On December 14th and 15th, the St. Anna Children’s Cancer Research Institute proudly hosted the inaugural International Workshop on Innovative Models for Neuroblastoma Research. This groundbreaking event gathered experts from Austria, the UK, the USA, Belgium, and Sweden, all converging at St. Anna CCRI

35 Years Anniversary Report Our anniversary report on the occasion of our 35th birthday is here! Under the motto “Reaching for the Stars“, embark on a journey through time of 35 Years St. Anna Children’s Cancer Research Institute, be inspired by exciting interviews with prominent supporters and get a detailed insight into our scientific milestones

35 Years of Pioneering Pediatric Cancer Research: An Anniversary Shaping the Future (Vienna, 05.12.2023) The St. Anna Children’s Cancer Research Institute celebrates 35 years at the forefront of scientific efforts against pediatric cancer. On this anniversary, the institute granted rare insights into its laboratories, showcasing the cutting-edge research that is conducted. Afterwards, the management presented

“Humor is always self-defense”  (Vienna, 29.11.2023) Comedian Aida Loos in a nutshell: She told us what humor means to her, what part of her job she values most and why she supports St. Anna Children’s Cancer Research Institute in our “Reaching for the Stars” interview! Under the motto of our 35th anniversary “Reaching for the stars”,

Joint Effort to Fast-Track Diagnoses (Vienna, 21.11.2023) Partners from two EU-funded initiatives, the European Joint Program for Rare Diseases (EJPRD) and The European Rare Diseases Research Coordination and Support Action (ERICA), converged at a joint conference in Amsterdam. The joint conference of EJPRD and ERICA served as a critical platform for participants to explore and

CLOSER Leukemia General Assembly: Sabine Strehl presents joint work package (Vienna, 20.11.2023) Sabine Strehl from St. Anna Childrens Cancer Research Institute, recently participated in the CLOSER Leukemia General Assembly in Santiago de Chile, presenting alongside her colleagues Patricia Rubio and Maria Sara Felice from Garrahan Hospital, Buenos Aires. They shared the latest outcomes from their